Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Schwenkglenks, Matthias; Pettengell, Ruth; Jackisch, Christian; Paridaens, Robert; Constenla, Manuel; Bosly, André; Szucs, Thomas D; Leonard, Robert
2011
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study
Pettengell, Ruth; Schwenkglenks, Matthias; Leonard, Robert; Bosly, André; Paridaens, Robert; Constenla, Manuel; Szucs, Thomas D; Jackisch, Christian; Impact of Neutropenia in Chemotherapy-European Study Group (INC-EU)
2008
Neutropenia occurrence and predictors of reduced chemotherapy delivery : results from the INC-EU prospective observational European neutropenia study
Panje, Cedric M.; Dedes, Konstantin J.; Matter-Walstra, Klazien; Schwenkglenks, Matthias; Gautschi, Oliver; Siano, Marco; Aebersold, Daniel M.; Plasswilm, Ludwig; Lupatsch, Judith E.
2018
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland
Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.